What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
CIK: 0002068251
Total reported value
$59.2M
$59.2M
3 檔
63.1%
The Q4 2025 SEC filing reveals that Gullane Capital, LLC held a total portfolio value of $59.2M, covering 3 public equity positions.
In Q4 2025, Gullane Capital, LLC adopted a defensive or profit-taking posture, trimming 1 positions and completely liquidating 2 holdings to manage risk exposure.
In terms of portfolio concentration, the top 5 core holdings (including CORZ, CORZW, PLTR) accounted for 63.1% of total reported equity market value during Q4 2025.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CORZ | Core Scientific Inc | Stock-Tech | 94.32% | -0.54% | -26.94% | |
| 2 | CORZW | Core Scientific Inc - 27 | Stock-Other | 3.19% | +1.18% | +80.10% | |
| 3 | PLTR | Palantir Technologies Inc-a | Stock-Tech | 2.49% | -1.02% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | CORZW | Core Scientific Inc - 27 | +1.7% | +80.10% | Add |
| 2 | PLTR | Palantir Technologies Inc-a | +1% | — | Unchanged |
| 3 | CORZ | Core Scientific Inc | -2.2% | -26.94% | Trim |
| 4 | NBIS | Nebius Group N.V. | — | EXIT | Sold out |
| 5 | CORZZ | Core Scientific Inc - 29 | — | EXIT | Sold out |
According to official SEC Form 13F filings, Gullane Capital, LLC reported a total U.S. public equity portfolio value of $59.2M across 3 disclosed positions in Q4 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Top Position Liquidated / Trimmed
NBIS
前期市值: $224.5K
During Q4 2025, Gullane Capital, LLC's top holdings by market value included CORZ (94.3%)、CORZW (3.2%)、PLTR (2.5%). The largest single position, CORZ, represented 94.3% of total portfolio value.
In Q4 2025, Gullane Capital, LLC made 4 total portfolio adjustments, initiating 0 new buys, adding to 1 positions, trimming 1 holdings, and fully liquidating 2 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.